A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and varying degrees of renal function
Crossref DOI link: https://doi.org/10.1007/s00280-014-2612-8
Published Online: 2014-11-07
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sharma, Sunil
Witteveen, Petronella O.
Lolkema, Martijn P.
Hess, Dagmar
Gelderblom, Hans
Hussain, Syed A.
Porro, Maria G.
Waldron, Edward
Valera, Sue-zette
Mu, Song
Text and Data Mining valid from 2014-11-07